Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 3/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18168695 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2CA14CNR2CNR1PPARG | |
| SCHEMBL8666640 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14 | |
| SCHEMBL8666638 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14 | |
| SCHEMBL14923139 | 0.77 | SMN1; SMN2 (0.36) | SMN1; SMN2CA14 | |
| SCHEMBL18168718 | 0.73 | GRIK1 (0.35) | — | |
| SCHEMBL11119968 | 0.73 | GRIK1 (0.35) | — | |
| SCHEMBL8666643 | 0.73 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14 | |
| SCHEMBL8669765 | 0.71 | ALDH1A1 (0.32) | — | |
| SCHEMBL27997196 | 0.71 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14 | |
| SCHEMBL27543338 | 0.71 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160311746-A1 | METHOD OF PRODUCING ADIPIC ACID OR AT LEAST A RESULTANT PRODUCT THEREOF | BASF SE (DE) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311746-A1 | METHOD OF PRODUCING ADIPIC ACID OR AT LEAST A RESULTANT PRODUCT THEREOF | ADIPOR1, FABP4, LIPA | SMN1; SMN2 4324/4885CA14 105/4885CNR2 2994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.